Our study also showed the co-occurrence of BRCA1 and TP53 mutations in exposed patients, a condition already observed in germline BRCA1 mutation carriers (40, 41) and found in colorectal cancer tumors, in which co-occurrence of BRCA1 and TP53 mutations resulted in poorer prognosis (42). The gene discussed is BRCA1; the disease is colorectal cancer.